Search Job Title Only
News By Subject
News by Disease
News By Date
Get Our FREE
Closes Ireland Site as U.S. Manufacturing Issues Causes Shortage of
5/1/2013 8:20:36 AM
Staying up-to-date has never been simpler. Sign up for the
free GenePool newsletter
Manufacturing disruptions at Lonza's Hopkinton, Massachusetts site are causing shortages of Ipsen Biopharmaceuticals’ growth failure treatment for children in both the US and EU, just as the company announces that it will shutter another manufacturing site in Ireland.
Help employers find you! Check out all the
post your resume
Another Biosimilar Product Setback?
Rethinking Pact With
Teva Pharmaceutical Industries Limited
(NVS) Reduces 40 Pct of Its Total Nebraska Workforce
Reach on Global Settlement Agreement for Endotoxin Detection Patents
Boehringer Ingelheim Corporation
to Restructure in Southern Europe, Jobs at Risk
to Invest $15.1 Million to Expand Antibody Drug Conjugate
454 Life Sciences
in Branford Laying Off 60 Workers
Active Biotech AB
(IPN.PA) Update the Analysis Plan for the 10TASQ10 Trial Evaluating Tasquinimod in the Treatment of Prostate Cancer
(AZN) Hires Sioux Falls Company Which Plans to Add 50 Jobs
Complete Sale of Haemophilia Assets
Delcath Systems, Inc.
(DCTH) Moving Headquarters to Queensbury, But Plans Job Cuts
comments powered by Disqus.
comments powered by
Biotech/Pharma - Industry, Jobs
Biotech/Pharma - Industry, Jobs (World)